The Humanistic and Economic Burden of Migraine in Europe: A Cross-Sectional Survey in Five Countries
Authors:
Open Access
- 15 June 2020
- journal article
- research article
- Published by Springer Nature in Neurology and Therapy
- Vol. 9 (2) , 535-549
Abstract
Introduction Prior studies have estimated the burden of migraine in patients suffering from ≥ 4 monthly headache days (MHDs), but the burden experienced by migraineurs suffering from one to three (1–3) MHDs is unknown. The aim of this study was to examine the incremental burden of migraine in terms of health-related quality of life (HRQoL), impairments to work and daily activities, and healthcare resource utilization (HRU) in five European countries (France, Germany, Italy, Spain, and the UK (EU5]), by comparing migraineurs with ≥ 4 MHDs and migraineurs with 1–3 MHDs. Methods The sample for this retrospective cross-sectional study was collected from the 2017 National Health and Wellness Survey (N = 62,000). The Short-Form 12-Item Health Survey Instrument, version-2 physical and mental component summary (PCS and MCS) scores, Short-Form 6-dimensions (SF-6D), EuroQoL 5-dimensions (EQ-5D) and EuroQoL visual analog scale (VAS) scores, impairments to work productivity and daily activities (Work Productivity and Activity Impairment [WPAI] Questionnaire) scores, and HRU were compared between migraineur groups with ≥ 4 MHDs (4–7, intermediate-frequency episodic migraine; 8–14, high-frequency episodic migraine; ≥ 15 chronic migraine) and the migraineur subgroup with 1−3 MHDs (low-frequency episodic migraine) using generalized linear modeling after adjusting for covariates. Results Data from a total of 62,000 survey respondents were examined, of whom 1323 and 1569 were considered to have 1–3 MHDs and ≥ 4 MHDs (4–7 MHDs [n = 783]; 8–14 MHDs [n = 429]; ≥ 15 MHDs [n = 357]), respectively. The adjusted HRQoL was significantly lower in the 4–7 MHDs (for MCS and SF-6D scores; p < 0.0001) and 8–14 MHDs subgroups (for MCS, SF-6D, EQ-5D, and EuroQoL VAS scores, p < 0.0001; for PCS scores, p = 0.0007) than in the 1–3 MHDs subgroup. Migraineurs with 4–7 and 8–14 MHDs reported higher activity impairment and more frequent visits to healthcare providers (all p < 0.0001) and neurologists (p = 0.0006 and p < 0.0001, respectively) compared to the 1–3 MHDs subgroup. Migraineurs with ≥ 15 MHDs had significantly lower HRQoL and increased WPAI scores and HRU than the 1–3 MHDs subgroup. Conclusions This study provides evidence supporting the incremental burden of migraine, characterized by poorer HRQoL and increased WPAI scores and greater HRU, among migraineurs experiencing ≥ 4 MHDs compared with migraineurs experiencing 1–3 MHDs in the EU5.Keywords
Funding Information
- Novartis Pharma AG, Switzerland
This publication has 28 references indexed in Scilit:
- Patients’ perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United KingdomThe Journal of Headache and Pain, 2018
- Migraine affects 1 in 10 people worldwide featuring recent rise: A systematic review and meta-analysis of community-based studies involving 6 million participantsJournal of the Neurological Sciences, 2017
- Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013The Lancet, 2015
- Comparisons of disability, quality of life, and resource use between chronic and episodic migraineurs: A clinic-based study in TaiwanCephalalgia, 2012
- Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS)Cephalalgia, 2010
- Assessing and Managing All Aspects of Migraine: Migraine Attacks, Migraine-Related Functional Impairment, Common Comorbidities, and Quality of LifeMayo Clinic Proceedings, 2009
- The Future of Migraine: Beyond Just Another PillMayo Clinic Proceedings, 2009
- Migraine Frequency and Health Utilities: Findings from a Multisite SurveyValue in Health, 2008
- Migraine prevalence, disease burden, and the need for preventive therapyNeurology, 2007
- Preface to the Second EditionCephalalgia, 2004